WallStreetZenWallStreetZen

NASDAQ: GLUE
Monte Rosa Therapeutics Inc Stock Ownership - Who owns Monte Rosa Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Monte Rosa Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Edmund DunnPrincipal Accounting Officer2026-03-04139$17.96
$2.50kSell
Edmund DunnPrincipal Accounting Officer2026-03-02536$17.50
$9.38kSell
Edmund DunnPrincipal Accounting Officer2026-03-02536$13.41
$7.19kBuy
Markus WarmuthPresident CEO2026-03-025,466$17.92
$97.97kSell
Edmund DunnPrincipal Accounting Officer2026-02-2725,164$18.10
$455.52kSell
Edmund DunnPrincipal Accounting Officer2026-02-2725,164$13.41
$337.45kBuy
Filip JankuChief Medical Officer2026-02-239,189$19.50
$179.16kSell
Markus WarmuthPresident CEO2026-01-07309$24.57
$7.59kSell
Markus WarmuthPresident CEO2026-01-071,450$23.88
$34.62kSell
Markus WarmuthPresident CEO2026-01-073,707$23.24
$86.16kSell

1 of 2

GLUE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GLUE insiders and whales buy or sell their stock.

GLUE Shareholders

What type of owners hold Monte Rosa Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bradley J. Phd Bolzon11.12%8,897,053$146.36MInsider
Versant Venture Capital VI LP9.69%7,750,860$127.50MInsider
Scott D. Sandell9.61%7,692,298$126.54MInsider
Peter W. Sonsini9.61%7,692,298$126.54MInsider
Paul Edward Walker9.61%7,692,298$126.54MInsider
Rick Yang9.61%7,692,298$126.54MInsider
New Enterprise Associates 17 LP9.61%7,692,298$126.54MInsider
Edward T. Mathers9.61%7,692,298$126.54MInsider
Joshua Makower9.61%7,692,298$126.54MInsider
Mohamad Makhzoumi9.61%7,692,298$126.54MInsider

1 of 3

GLUE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GLUE34.80%65.20%Net SellingNet Selling
IMTX75.83%8.28%
NVAX72.31%17.25%Net SellingNet Selling
BCAX72.98%27.02%Net BuyingNet Buying
OLMA78.20%21.80%Net SellingNet Selling
View Top Biotech Stocks

Monte Rosa Therapeutics Stock Ownership FAQ

Who owns Monte Rosa Therapeutics?

Monte Rosa Therapeutics (NASDAQ: GLUE) is owned by 80.57% institutional shareholders, 150.94% Monte Rosa Therapeutics insiders, and 0.00% retail investors. Bradley J. Phd Bolzon is the largest individual Monte Rosa Therapeutics shareholder, owning 8.90M shares representing 11.12% of the company. Bradley J. Phd Bolzon's Monte Rosa Therapeutics shares are currently valued at $146.36M.

If you're new to stock investing, here's how to buy Monte Rosa Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.